investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Pinar Ozden Eser

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Pinar Ozden Eser

Harvard University

Cambridge, United States

Related projects

David Kozono

Characterization of lung cancer radiosensitizers from genome-wide RNAi screens

Trachea, bronchus and lung

Curtis Harris

Integrative Molecular Epidemiology of Human Cancer

Trachea, bronchus and lung

Hematology and hematologic malignancies

Hugo Aerts

Genotype and Imaging Phenotype Biomarkers in Lung Cancer

Trachea, bronchus and lung

Amato J Giaccia

Tumor Hypoxia: Molecular Studies and Clinical Exploitation

Trachea, bronchus and lung

Radiation Oncology

Deborah Morrison

Role of Protein Scaffolds in RTK/Ras-Dependent Signal Transduction

Trachea, bronchus and lung

Fred R Hirsch

Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Prognosis

Trachea, bronchus and lung

Pathology

William Stetler-Stevenson

The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis

Trachea, bronchus and lung

Sara Lindstroem

Quantifying and Characterizing the shared genetic contribution to common cancers

Trachea, bronchus and lung

Mizuki Nishino

CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation

Trachea, bronchus and lung